BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24852474)

  • 61. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery.
    Kaplan AL; Weitzul SB; Taylor RS
    Dermatol Surg; 2008 Jan; 34(1):15-9. PubMed ID: 18053056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
    Gibson GE; Ahmed I
    J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Life expectancy after Mohs micrographic surgery in patients aged 90 years and older.
    Delaney A; Shimizu I; Goldberg LH; MacFarlane DF
    J Am Acad Dermatol; 2013 Feb; 68(2):296-300. PubMed ID: 23200199
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor characteristics of Mohs surgery patients in Ottawa, Canada versus Houston, Texas--a consequence of access to care?
    Beach RA; Zhang T; Goldberg LH; Walker JD; Mamelak AJ
    Dermatol Surg; 2011 Aug; 37(8):1106-12. PubMed ID: 21635629
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mohs micrographic surgery for the treatment of difficult skin cancers.
    Skouge JW
    Md Med J; 1997; 46(5):231-7. PubMed ID: 9159052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
    Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
    Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
    Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
    Alcalay J; Alkalay R; Hazaz B
    Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
    Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
    JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mohs micrographic surgery as treatment option for non-basal cell or squamous cell carcinomas in the United States.
    Puyana C; Zimmerman L; Tsoukas MM
    J Dermatolog Treat; 2020 Sep; 31(6):567-570. PubMed ID: 31474170
    [No Abstract]   [Full Text] [Related]  

  • 74. Removal of Incidental Skin Cancer During Mohs Micrographic Surgery Indicated for a Different Primary Tumor.
    Darsha AK; Pousti BT; Loh TY; Hau JT; Brian Jiang SI
    Dermatol Surg; 2024 Apr; 50(4):327-330. PubMed ID: 38261759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer.
    Batra RS; Kelley LC
    Dermatol Surg; 2002 Feb; 28(2):107-12; discussion 112. PubMed ID: 11860418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
    Thomas CJ; Wood GC; Marks VJ
    Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A retrospective study of squamous cell carcinoma of the nail unit diagnosed in a Belgian general hospital over a 15-year period.
    Lecerf P; Richert B; Theunis A; André J
    J Am Acad Dermatol; 2013 Aug; 69(2):253-61. PubMed ID: 23582571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mohs micrographic surgery referral patterns: the University of Missouri experience.
    Gaston DA; Naugle C; Clark DP
    Dermatol Surg; 1999 Nov; 25(11):862-6; discussion 866-7. PubMed ID: 10594598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
    Schinstine M; Goldman GD
    J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mohs micrographic surgery using a flexible blade for tumors of the scalp.
    Vujevich JJ; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2009 Jul; 35(7):1130-3. PubMed ID: 19438683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.